The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Provision of antigen and CD137 signaling breaks immunological ignorance, promoting regression of poorly immunogenic tumors
Open accessAbstract
Treatment of advanced, poorly immunogenic tumors in animal models, considered the closest simulation available thus far for conditions observed in cancer patients, remains a major challenge for cancer immunotherapy. We reported previously that established tumors in mice receiving an agonistic mAb to the T cell costimulatory molecule 4-1BB (CD137) regress due to enhanced tumor antigen-specific cytotoxic T lymphocyte responses. In this study, we demonstrate that several poorly immunogenic tumors, including C3 tumor, TC-1 lung carcinoma, and B16-F10 melanoma, once established as solid tumors or metastases, are refractory to treatment by anti-4-1BB mAb. We provide evidence that immunological ignorance, rather than anergy or deletion, of tumor antigen--specific CTLs during the progressive growth of tumors prevents costimulation by anti-4-1BB mAb. Breaking CTL ignorance by immunization with a tumor antigen-derived peptide, although insufficient to stimulate a curative CTL response, is necessary for anti--4-1BB mAb to induce a CTL response leading to the regression of established tumors. Our results suggest a new approach for immunotherapy of human cancers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dranoff, G., Jaffee, E., Lazenby, A., Golumbek, P., Levitsky, H., Brose, K., Jackson, V, Hamada, H., Pardoll, D., & Mulligan, R. C. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.8.3539 · Cited by 2,818
Papillomavirus infections — a major cause of human cancers
Hausen, H. Z. (1996) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(96)00020-0 · Cited by 1,513
Introduction of soluble protein into the class I pathway of antigen processing and presentation
Moore, M. W., Carbone, F. R., & Bevan, M. J. (1988) · Cell · doi:10.1016/s0092-8674(88)91043-4 · Cited by 1,092
Lin, K. Y., Guarnieri, F., Staveley-O’Carroll, K. F., Levitsky, H. I., August, J. T., Pardoll, D. M., & Wu, T. ‐. (1996) · PubMed · Cited by 1,003
Monoclonal antibodies against the 4-1BB T-cell activation molecule eradicate established tumors
Melero, I., Shuford, W. W., Newby, S. A., Aruffo, A., Ledbetter, J. A., Hellström, K. E., Mittler, R. S., & Chen, L. (1997) · Nature Medicine · doi:10.1038/nm0697-682 · Cited by 898
Self-citationFeltkamp, M. C. W., Smits, H. L., Vierboom, M. P. M., Minnaar, R. P., De Jongh, B. M., Drijfhout, J. W., Schegget, J. T., Melief, C. J. M., & Kast, W. M. (1993) · European Journal of Immunology · doi:10.1002/eji.1830230929 · Cited by 825
Shuford, W. W., Klussman, K., Tritchler, D. D., Loo, D. T., Chalupny, J., Siadak, A. W., Brown, T. J., Emswiler, J., Raecho, H., Larsen, C. P., et al. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.1.47 · Cited by 804
Induction of antigen-specific T cell anergy: An early event in the course of tumor progression
Staveley-O’Carroll, K., Sotomayor, E., Montgomery, J., Borrello, I., Hwang, L., Fein, S., Pardoll, D., & Levitsky, H. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.3.1178 · Cited by 704
Immune surveillance against a solid tumor fails because of immunological ignorance
Ochsenbein, A. F., Klenerman, P., Karrer, U., Ludewig, B., Pericin, M., Hengartner, H., & Zinkernagel, R. M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.5.2233 · Cited by 453
Inducible T cell antigen 4-1BB. Analysis of expression and function
Pollok, K. E., Kim, Y. J., Zhou, Z., Hurtado, J., Kim, K. K., Pickard, R. T., & Kwon, B. S. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.150.3.771 · Cited by 421
Identification of Tyrosinase-related Protein 2 as a Tumor Rejection Antigen for the B16 Melanoma
Bloom, M. B., Perry-Lalley, D., Robbins, P. F., Li, Y., El-Gamil, M., Rosenberg, S. A., & Yang, J. C. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.3.453 · Cited by 401
Cutting Edge: 4-1BB Is a Bona Fide CD8 T Cell Survival Signal
Takahashi, C., Mittler, R. S., & Vella, A. T. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.9.5037 · Cited by 379
Melero, I., Johnston, J. V., Shufford, W. W., Mittler, R. S., & Chen, L. (1998) · Cellular Immunology · doi:10.1006/cimm.1998.1396 · Cited by 363
Self-citationCD28-independent, TRAF2-dependent Costimulation of Resting T Cells by 4-1BB Ligand
Saoulli, K., Lee, S. Y., Cannons, J. L., Yeh, W. C., Santana, A., Goldstein, M. D., Bangia, N., DeBenedette, M. A., Mak, T. W., Choi, Y., et al. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.11.1849 · Cited by 322
Costimulation of CD28- T lymphocytes by 4-1BB ligand
DeBenedette, M. A., Shahinian, A., Mak, T. W., & Watts, T. H. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.2.551 · Cited by 320
Role of 4-1BB in immune responses
Vinay, D. S., & Kwon, B. S. (1998) · Seminars in Immunology · doi:10.1006/smim.1998.0157 · Cited by 312
Tamada, K., Shimozaki, K., Chapoval, A. I., Zhu, G., Sica, G., Flies, D., Boone, T., Hsu, H., Fu, Y.-X., Nagata, S., et al. (2000) · Nature Medicine · doi:10.1038/73136 · Cited by 303
Self-citationDeBenedette, M. A., Wen, T., Bachmann, M. F., Ohashi, P. S., Barber, B. H., Stocking, K. L., Peschon, J. J., & Watts, T. H. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.9.4833 · Cited by 282
Tan, J. T., Whitmire, J. K., Ahmed, R., Pearson, T. C., & Larsen, C. P. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.9.4859 · Cited by 259
Hurtado, J. C., Kim, Y. J., & Kwon, B. S. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.6.2600 · Cited by 257
CD8 T cell ignorance or tolerance to islet antigens depends on antigen dose
Kurts, C., Sutherland, R. M., Davey, G., Li, M., Lew, A. M., Blanas, E., Carbone, F. R., Miller, J. F. A. P., & Heath, W. R. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.22.12703 · Cited by 245
Melero, I., Bach, N., Hellström, K. E., Aruffo, A., Mittler, R. S., & Chen, L. (1998) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199803)28:03<1116::aid-immu1116>3.0.co;2-a · Cited by 217
Self-citationHER-2/neu is a tumor rejection target in tolerized HER-2/neu transgenic mice.
Reilly, R. T., Gottlieb, M. B. C., Ercolini, A. M., Machiels, J. P., Kane, C. E., Okoye, F. I., Muller, W. J., Dixon, K. H., & Jaffee, E. M. (2000) · PubMed · Cited by 215
Wick, M., Dubey, P., Koeppen, H., Siegel, C. T., Fields, P. E., Chen, L., Bluestone, J. A., & Schreiber, H. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.2.229 · Cited by 195
Self-citationzur Hausen, H. (1999) · Seminars in Cancer Biology · doi:10.1006/scbi.1999.0144 · Cited by 181
Curtsinger, J. M., Lins, D. C., & Mescher, M. F. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.7.3236 · Cited by 177
Where have all the T cells gone? Mechanisms of immune evasion by tumors
Finke, J. H., Ferrone, S., Frey, A. B., Mufson, A., & Ochoa, A. C. (1999) · Immunology Today · doi:10.1016/s0167-5699(98)01435-2 · Cited by 150
4-1BB Costimulation Is Required for Protective Anti-Viral Immunity After Peptide Vaccination
Tan, J. T., Whitmire, J. K., Murali‐Krishna, K., Ahmed, R., Altman, J. D., Mittler, R. S., Sette, A., Pearson, T. C., & Larsen, C. P. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.5.2320 · Cited by 139
Guinn, B., Debenedette, M. A., Watts, T. H., & Berinstein, N. L. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.8.5003 · Cited by 136
Schreurs, M. W. J., Eggert, A. A. O., de Boer, A. J., Vissers, J. L. M., van Hall, T., Offringa, R., Figdor, C. G., & Adema, G. J. (2000) · PubMed · Cited by 125
Martinet, O., Ermekova, V., Qiao, J. Q., Sauter, B., Mandeli, J., Chen, L., & Chen, S. H. (2000) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/92.11.931 · Cited by 122
Self-citationJohnson, A. J., Njenga, M. K., Hansen, M. J., Kuhns, S. T., Chen, L., Rodriguez, M., & Pease, L. R. (1999) · Journal of Virology · doi:10.1128/jvi.73.5.3702-3708.1999 · Cited by 114
Self-citationJohnston, J. V., Malacko, A. R., Mizuno, M. T., McGowan, P., Hellström, I., Hellström, K. E., Marquardt, H., & Chen, L. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.183.3.791 · Cited by 96
Self-citationImmunological ignorance of silent antigens as an explanation of tumor evasion
Chen, L. (1998) · Immunology Today · doi:10.1016/s0167-5699(97)01180-8 · Cited by 90
Self-citationChen, S., Pham-Nguyen, K. B., Martinet, O., Huang, Y., Yang, W., Thung, S. N., Chen, L., Mittler, R. S., & Woo, S. L. C. (2000) · Molecular Therapy · doi:10.1006/mthe.2000.0086 · Cited by 87
Self-citationMelero, I., Singhal, M. C., McGowan, P., Haugen, H. S., Blake, J., Hellström, K. E., Yang, G., Clegg, C. H., & Chen, L. (1997) · Journal of Virology · doi:10.1128/jvi.71.5.3998-4004.1997 · Cited by 85
Self-citationKienzle, G., & von Kempis, J. (2000) · International Immunology · doi:10.1093/intimm/12.1.73 · Cited by 84
Role of the Stress Kinase Pathway in Signaling Via the T Cell Costimulatory Receptor 4-1BB
Cannons, J. L., Hoeflich, K. P., Woodgett, J. R., & Watts, T. H. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.6.2990 · Cited by 65
Hermans, I. F., Daish, A., Yang, J., Ritchie, D., & Ronchese, F. (1998) · PubMed · Cited by 60
van Hall, T., van Bergen, J., van Veelen, P. A., Kraakman, M. E. M., Heukamp, L. C., Koning, F., Melief, C. J. M., OSSENDORP, F. A., & Offringa, R. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.2.869 · Cited by 49
Modulation of the Immune Response Through 4-1BB
Sica, G., & Chen, L. (2002) · Advances in experimental medicine and biology · doi:10.1007/0-306-46817-4_30 · Cited by 44
Self-citationNot just another meeting: the coming of age of JAKs and STATs
Chen, E. H., Gadina, M., Galon, J., Chen, M., & O’Shea, J. J. (1998) · Immunology Today · doi:10.1016/s0167-5699(98)01295-x · Cited by 16
Cited by
Blockade of B7-H1 and PD-1 by monoclonal antibodies potentiates cancer therapeutic immunity
Hirano, F., Kaneko, K., Tamura, H., Dong, H., Wang, S., Ichikawa, M., Rietz, C., Flies, D. B., Lau, J. S., Zhu, G., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.1089.65.3 · Cited by 1,018
Self-citationDendritic-Cell-Based Therapeutic Cancer Vaccines
Palucka, K., & Banchereau, J. (2013) · Immunity · doi:10.1016/j.immuni.2013.07.004 · Cited by 869
Co-stimulatory members of the TNFR family: keys to effective T-cell immunity?
Croft, M. (2003) · Nature Reviews Immunology · doi:10.1038/nri1148 · Cited by 863
B7-H4, a Molecule of the B7 Family, Negatively Regulates T Cell Immunity
Sica, G. L., Choi, I.-H., Zhu, G., Tamada, K., Wang, S.-D., Tamura, H., Chapoval, A. I., Flies, D. B., Bajorath, J., & Chen, L. (2003) · Immunity · doi:10.1016/s1074-7613(03)00152-3 · Cited by 713
Self-citationImmunostimulatory monoclonal antibodies for cancer therapy
Melero, I., Hervas-Stubbs, S., Glennie, M., Pardoll, D. M., & Chen, L. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2051 · Cited by 627
Self-citation
Metadata
- Authors
- Wilcox, R. A., Flies, D. B., Zhu, G., Johnson, A. J., Tamada, K., Chapoval, A. I., Strome, S. E., Pease, L. R., & Chen, L.
- Venue
- Journal of Clinical Investigation
- Published
- 2002-03-01
- Volume
- 109
- Issue
- 5
- Pages
- 651-659
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W1970230889
- Cited by
- 259
- References
- 42
- FWCI
- 6.36
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.